Selected research
Industry Research
Pet Medical Cannabidiol Industry Research Report 2026
Market perspective
The global Pet Medical Cannabidiol market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pet Medical Cannabidiol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pet Medical Cannabidiol is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pet Medical Cannabidiol is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pet Medical Cannabidiol include Canna-Pet, Holistic Hound, BATCH, Choom Holdings, Receptra Naturals, Curaleaf, Trulieve Cannabis, Pure Spectrum and Cannabis Strategies Acquisition, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pet Medical Cannabidiol market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pet Medical Cannabidiol Market by Company
Canna-Pet
Holistic Hound
BATCH
Choom Holdings
Receptra Naturals
Curaleaf
Trulieve Cannabis
Pure Spectrum
Cannabis Strategies Acquisition
Pet Releaf
Diamond CBD
PotNetwork Holdings
Kat's Naturals
Bluebird Botanicals
Pet Medical Cannabidiol Segment by Type
Oral Cannabidiol
Topical Cannabidiol
Pet Medical Cannabidiol Segment by Application
Anaesthetization
Stimulate Appetite
Relieve Anxiety
Others
Pet Medical Cannabidiol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Medical Cannabidiol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Medical Cannabidiol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Medical Cannabidiol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pet Medical Cannabidiol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pet Medical Cannabidiol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pet Medical Cannabidiol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Cannabidiol
- Topical Cannabidiol
Applications
- Anaesthetization
- Stimulate Appetite
- Relieve Anxiety
- Others
Companies covered
- Canna-Pet
- Holistic Hound
- BATCH
- Choom Holdings
- Receptra Naturals
- Curaleaf
- Trulieve Cannabis
- Pure Spectrum
- Cannabis Strategies Acquisition
- Pet Releaf
- Diamond CBD
- PotNetwork Holdings
- Kat's Naturals
- Bluebird Botanicals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pet Medical Cannabidiol Market Size (2021-2032)
- 2.2.2 Global Pet Medical Cannabidiol Sales (2021-2032)
- 2.2.3 Global Pet Medical Cannabidiol Market Average Price (2021-2032)
- 2.3 Pet Medical Cannabidiol by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral Cannabidiol
- 2.3.3 Topical Cannabidiol
- 2.4 Pet Medical Cannabidiol by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Anaesthetization
- 2.4.3 Stimulate Appetite
- 2.4.4 Relieve Anxiety
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pet Medical Cannabidiol Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pet Medical Cannabidiol Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Pet Medical Cannabidiol Revenue of Manufacturers (2021-2026)
- 3.4 Global Pet Medical Cannabidiol Average Price by Manufacturers (2021-2026)
- 3.5 Global Pet Medical Cannabidiol Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pet Medical Cannabidiol, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pet Medical Cannabidiol, Product Type & Application
- 3.8 Global Manufacturers of Pet Medical Cannabidiol, Established Date
- 3.9 Global Pet Medical Cannabidiol Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Canna-Pet
- 4.1.1 Canna-Pet Company Information
- 4.1.2 Canna-Pet Business Overview
- 4.1.3 Canna-Pet Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Canna-Pet Pet Medical Cannabidiol Product Portfolio
- 4.1.5 Canna-Pet Recent Developments
- 4.2 Holistic Hound
- 4.2.1 Holistic Hound Company Information
- 4.2.2 Holistic Hound Business Overview
- 4.2.3 Holistic Hound Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Holistic Hound Pet Medical Cannabidiol Product Portfolio
- 4.2.5 Holistic Hound Recent Developments
- 4.3 BATCH
- 4.3.1 BATCH Company Information
- 4.3.2 BATCH Business Overview
- 4.3.3 BATCH Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 BATCH Pet Medical Cannabidiol Product Portfolio
- 4.3.5 BATCH Recent Developments
- 4.4 Choom Holdings
- 4.4.1 Choom Holdings Company Information
- 4.4.2 Choom Holdings Business Overview
- 4.4.3 Choom Holdings Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Choom Holdings Pet Medical Cannabidiol Product Portfolio
- 4.4.5 Choom Holdings Recent Developments
- 4.5 Receptra Naturals
- 4.5.1 Receptra Naturals Company Information
- 4.5.2 Receptra Naturals Business Overview
- 4.5.3 Receptra Naturals Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Receptra Naturals Pet Medical Cannabidiol Product Portfolio
- 4.5.5 Receptra Naturals Recent Developments
- 4.6 Curaleaf
- 4.6.1 Curaleaf Company Information
- 4.6.2 Curaleaf Business Overview
- 4.6.3 Curaleaf Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Curaleaf Pet Medical Cannabidiol Product Portfolio
- 4.6.5 Curaleaf Recent Developments
- 4.7 Trulieve Cannabis
- 4.7.1 Trulieve Cannabis Company Information
- 4.7.2 Trulieve Cannabis Business Overview
- 4.7.3 Trulieve Cannabis Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Trulieve Cannabis Pet Medical Cannabidiol Product Portfolio
- 4.7.5 Trulieve Cannabis Recent Developments
- 4.8 Pure Spectrum
- 4.8.1 Pure Spectrum Company Information
- 4.8.2 Pure Spectrum Business Overview
- 4.8.3 Pure Spectrum Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pure Spectrum Pet Medical Cannabidiol Product Portfolio
- 4.8.5 Pure Spectrum Recent Developments
- 4.9 Cannabis Strategies Acquisition
- 4.9.1 Cannabis Strategies Acquisition Company Information
- 4.9.2 Cannabis Strategies Acquisition Business Overview
- 4.9.3 Cannabis Strategies Acquisition Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Cannabis Strategies Acquisition Pet Medical Cannabidiol Product Portfolio
- 4.9.5 Cannabis Strategies Acquisition Recent Developments
- 4.10 Pet Releaf
- 4.10.1 Pet Releaf Company Information
- 4.10.2 Pet Releaf Business Overview
- 4.10.3 Pet Releaf Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pet Releaf Pet Medical Cannabidiol Product Portfolio
- 4.10.5 Pet Releaf Recent Developments
- 4.11 Diamond CBD
- 4.11.1 Diamond CBD Company Information
- 4.11.2 Diamond CBD Business Overview
- 4.11.3 Diamond CBD Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Diamond CBD Pet Medical Cannabidiol Product Portfolio
- 4.11.5 Diamond CBD Recent Developments
- 4.12 PotNetwork Holdings
- 4.12.1 PotNetwork Holdings Company Information
- 4.12.2 PotNetwork Holdings Business Overview
- 4.12.3 PotNetwork Holdings Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 PotNetwork Holdings Pet Medical Cannabidiol Product Portfolio
- 4.12.5 PotNetwork Holdings Recent Developments
- 4.13 Kat's Naturals
- 4.13.1 Kat's Naturals Company Information
- 4.13.2 Kat's Naturals Business Overview
- 4.13.3 Kat's Naturals Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Kat's Naturals Pet Medical Cannabidiol Product Portfolio
- 4.13.5 Kat's Naturals Recent Developments
- 4.14 Bluebird Botanicals
- 4.14.1 Bluebird Botanicals Company Information
- 4.14.2 Bluebird Botanicals Business Overview
- 4.14.3 Bluebird Botanicals Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Bluebird Botanicals Pet Medical Cannabidiol Product Portfolio
- 4.14.5 Bluebird Botanicals Recent Developments
5 Global Pet Medical Cannabidiol Market Scenario by Region
- 5.1 Global Pet Medical Cannabidiol Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pet Medical Cannabidiol Sales by Region: 2021-2032
- 5.2.1 Global Pet Medical Cannabidiol Sales by Region: 2021-2026
- 5.2.2 Global Pet Medical Cannabidiol Sales by Region: 2027-2032
- 5.3 Global Pet Medical Cannabidiol Revenue by Region: 2021-2032
- 5.3.1 Global Pet Medical Cannabidiol Revenue by Region: 2021-2026
- 5.3.2 Global Pet Medical Cannabidiol Revenue by Region: 2027-2032
- 5.4 North America Pet Medical Cannabidiol Market Facts & Figures by Country
- 5.4.1 North America Pet Medical Cannabidiol Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pet Medical Cannabidiol Sales by Country (2021-2032)
- 5.4.3 North America Pet Medical Cannabidiol Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pet Medical Cannabidiol Market Facts & Figures by Country
- 5.5.1 Europe Pet Medical Cannabidiol Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pet Medical Cannabidiol Sales by Country (2021-2032)
- 5.5.3 Europe Pet Medical Cannabidiol Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pet Medical Cannabidiol Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pet Medical Cannabidiol Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pet Medical Cannabidiol Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pet Medical Cannabidiol Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pet Medical Cannabidiol Market Facts & Figures by Country
- 5.7.1 South America Pet Medical Cannabidiol Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pet Medical Cannabidiol Sales by Country (2021-2032)
- 5.7.3 South America Pet Medical Cannabidiol Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pet Medical Cannabidiol Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pet Medical Cannabidiol Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pet Medical Cannabidiol Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pet Medical Cannabidiol Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pet Medical Cannabidiol Sales by Type (2021-2032)
- 6.1.1 Global Pet Medical Cannabidiol Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Pet Medical Cannabidiol Sales Market Share by Type (2021-2032)
- 6.2 Global Pet Medical Cannabidiol Revenue by Type (2021-2032)
- 6.2.1 Global Pet Medical Cannabidiol Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pet Medical Cannabidiol Revenue Market Share by Type (2021-2032)
- 6.3 Global Pet Medical Cannabidiol Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pet Medical Cannabidiol Sales by Application (2021-2032)
- 7.1.1 Global Pet Medical Cannabidiol Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Pet Medical Cannabidiol Sales Market Share by Application (2021-2032)
- 7.2 Global Pet Medical Cannabidiol Revenue by Application (2021-2032)
- 7.2.1 Global Pet Medical Cannabidiol Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pet Medical Cannabidiol Revenue Market Share by Application (2021-2032)
- 7.3 Global Pet Medical Cannabidiol Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pet Medical Cannabidiol Value Chain Analysis
- 8.1.1 Pet Medical Cannabidiol Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pet Medical Cannabidiol Production Mode & Process
- 8.2 Pet Medical Cannabidiol Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pet Medical Cannabidiol Distributors
- 8.2.3 Pet Medical Cannabidiol Customers
9 Global Pet Medical Cannabidiol Analyzing Market Dynamics
- 9.1 Pet Medical Cannabidiol Industry Trends
- 9.2 Pet Medical Cannabidiol Industry Drivers
- 9.3 Pet Medical Cannabidiol Industry Opportunities and Challenges
- 9.4 Pet Medical Cannabidiol Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst